ABL, an Institut Mérieux company

ABL is a US based CDMO serving clients globally. We bring 63+ yrs of expertise advancing programs across Cell & Gene therapies, Vaccines and Oncolytics, from development through clinical manufacturing. We offer an extensive range of development and manufacturing services. Our 'collaboratory' includes dynamic partnering across government and commercial programs. Leveraging decades of customer experience enables our clients to accelerate life-changing therapies to their patients, and the world.